CA2614979C - Polymorphe de piretanide, procede pour sa preparation et son utilisation - Google Patents

Polymorphe de piretanide, procede pour sa preparation et son utilisation Download PDF

Info

Publication number
CA2614979C
CA2614979C CA2614979A CA2614979A CA2614979C CA 2614979 C CA2614979 C CA 2614979C CA 2614979 A CA2614979 A CA 2614979A CA 2614979 A CA2614979 A CA 2614979A CA 2614979 C CA2614979 C CA 2614979C
Authority
CA
Canada
Prior art keywords
piretanide
polymorph
value
amorphous
solubility
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2614979A
Other languages
English (en)
Other versions
CA2614979A1 (fr
Inventor
Yuji Chikaraishi
Yoshihisa Matsuda
Makoto Otsuka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst Pharmaceuticals and Chemicals KK
Original Assignee
Hoechst Pharmaceuticals and Chemicals KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP03321695A external-priority patent/JP3532988B2/ja
Priority claimed from JP03321595A external-priority patent/JP3532987B2/ja
Application filed by Hoechst Pharmaceuticals and Chemicals KK filed Critical Hoechst Pharmaceuticals and Chemicals KK
Priority claimed from CA002213693A external-priority patent/CA2213693C/fr
Publication of CA2614979A1 publication Critical patent/CA2614979A1/fr
Application granted granted Critical
Publication of CA2614979C publication Critical patent/CA2614979C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2614979A 1995-02-22 1996-02-12 Polymorphe de piretanide, procede pour sa preparation et son utilisation Expired - Lifetime CA2614979C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP7/33216 1995-02-22
JP7/33215 1995-02-22
JP03321695A JP3532988B2 (ja) 1995-02-22 1995-02-22 ピレタニドの新規な結晶多形およびその製造方法
JP03321595A JP3532987B2 (ja) 1995-02-22 1995-02-22 新規な無晶形ピレタニドおよびその製造方法
CA002213693A CA2213693C (fr) 1995-02-22 1996-02-12 Piretanide amorphe, polymorphes de piretanide, leur procede de preparation et leur utilisation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002213693A Division CA2213693C (fr) 1995-02-22 1996-02-12 Piretanide amorphe, polymorphes de piretanide, leur procede de preparation et leur utilisation

Publications (2)

Publication Number Publication Date
CA2614979A1 CA2614979A1 (fr) 1996-08-29
CA2614979C true CA2614979C (fr) 2011-03-22

Family

ID=39264350

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2614979A Expired - Lifetime CA2614979C (fr) 1995-02-22 1996-02-12 Polymorphe de piretanide, procede pour sa preparation et son utilisation

Country Status (1)

Country Link
CA (1) CA2614979C (fr)

Also Published As

Publication number Publication date
CA2614979A1 (fr) 1996-08-29

Similar Documents

Publication Publication Date Title
KR100589299B1 (ko) 멜록시캄을 포함하는 경구 투여용 생약 제형
AU2011213742C1 (en) Crystal Form of Quinoline Compound and Process for its Production
CN101910189B (zh) 吡唑衍生物的单癸二酸盐
JP5043825B2 (ja) Ｄｐｐ−ｉｖ阻害剤の新規な塩及び多形
US20070276015A1 (en) Crystal modification of torasemide
JP2000512992A (ja) 多形性化合物
US6096779A (en) Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
CA2614979C (fr) Polymorphe de piretanide, procede pour sa preparation et son utilisation
KR20040104020A (ko) 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제
JPH0678232B2 (ja) アンジオテンシンｉ転換酵素阻害剤
SU1056901A3 (ru) Способ получени сесквитерпеновых производных или их солей
EP0704214B1 (fr) Procédé de préparation de nizatidine pure
US6060498A (en) Composition containing antitumor agent
JP3532988B2 (ja) ピレタニドの新規な結晶多形およびその製造方法
JP3532987B2 (ja) 新規な無晶形ピレタニドおよびその製造方法
KR100673508B1 (ko) 신규 아세클로페낙의 아미노산염 및 이 염을 유효성분으로함유하는 약학적 제제
KR102150825B1 (ko) 새로운 sglt-2 억제제의 신규한 공결정
BR102023002771A2 (pt) Tetrahidroclorito de trientina e um método de preparação e sua composição farmacêutica
KR20210017070A (ko) 신규한 티카그렐러의 결정형, 이의 제조방법 또는 용도
HK1006783B (en) Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
KR19980035382A (ko) 신규한 비페닐 디카르복실산 유도체와 이의 제조방법
CN110804057A (zh) 替比培南酯氢溴酸盐晶型及其制备方法、药物组合物和制药用途
MXPA00007921A (en) Novel galenic formulations of meloxicam for oral administration
NO335256B1 (no) Krystall form (form A og C) av N-(3-cyano-4-metyl-1H-indol-7-yl)-3-cyanobenzensulfonamid og fremgangsmåte for fremstilling derav
JPH06256185A (ja) ビタミンｅ誘導体およびそれを有効成分とする抗潰瘍剤

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20160212